Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation.

Background Whether antiarrhythmic drugs improve the rate of successful resuscitation after out-of-hospital cardiac arrest has not been determined in randomized clinical trials. Methods We conducted a randomized, double-blind, placebo-controlled study of intravenous amiodarone in patients with out-of-hospital cardiac arrest. Patients who had cardiac arrest with ventricular fibrillation (or pulseless ventricular tachycardia) and who had not been resuscitated after receiving three or more precordial shocks were randomly assigned to receive 300 mg of intravenous amiodarone (246 patients) or placebo (258 patients). Results The treatment groups had similar clinical profiles. There was no significant difference between the amiodarone and placebo groups in the mean (±SD) duration of the resuscitation attempt (42±16 and 43±16 minutes, respectively), the number of shocks delivered (4±3 and 6±5), or the proportion of patients who required additional antiarrhythmic drugs after the administration of the study drug (66...

[1]  C. Case,et al.  Rhythm changes during resuscitation from ventricular fibrillation. , 1993, Resuscitation.

[2]  Effect of injection site on circulation times during cardiac arrest. , 1988, Critical care medicine.

[3]  P. Kowey,et al.  Dose-Ranging Study of Intravenous Amiodarone in Patients With Life-Threatening Ventricular Tachyarrhythmias , 1995 .

[4]  M. Copass,et al.  Considerations for improving survival from out-of-hospital cardiac arrest. , 1986, Annals of emergency medicine.

[5]  A. Choussat,et al.  [Hemodynamic effects of intravenous amiodarone in humans]. , 1977, Archives des maladies du coeur et des vaisseaux.

[6]  E. Harrison.  Lidocaine in prehospital countershock refractory ventricular fibrillation. , 1981, Annals of emergency medicine.

[7]  A. Jaffe.  The use of antiarrhythmics in advanced cardiac life support. , 1993, Annals of emergency medicine.

[8]  W. Weaver.  Resuscitation outside the hospital--what's lacking? , 1991, The New England journal of medicine.

[9]  A. Hallstrom,et al.  COMMUNITY‐BASED CARDIOPULMONARY RESUSCITATION: WHAT HAVE WE LEARNED? * , 1982, Annals of the New York Academy of Sciences.

[10]  C. Emerman,et al.  The effect of bolus injection on circulation times during cardiac arrest. , 1990, The American journal of emergency medicine.

[11]  H. Refsum,et al.  Acute electrophysiologic and blood pressure effects of amiodarone and its solvent in the dog. , 2009, Acta pharmacologica et toxicologica.

[12]  N. El-Sherif,et al.  Hypotensive Action of Commercial Intravenous Amiodarone and Polysorbate 80 in Dogs , 1982, Journal of cardiovascular pharmacology.

[13]  L. Bossaert,et al.  Guidelines for advanced life support , 1992 .

[14]  J. Darin,et al.  A randomized comparison study of bretylium tosylate and lidocaine in resuscitation of patients from out-of-hospital ventricular fibrillation in a paramedic system. , 1984, Annals of emergency medicine.

[15]  R. Nowak,et al.  Bretylium tosylate as initial treatment for cardiopulmonary arrest: randomized comparison with placebo. , 1981, Annals of emergency medicine.

[16]  C. Weston,et al.  Predicting survival from out-of-hospital cardiac arrest: a multivariate analysis. , 1997, Resuscitation.

[17]  M. Copass,et al.  Comparison of bretylium tosylate and lidocaine in management of out of hospital ventricular fibrillation: a randomized clinical trial. , 1981, The American journal of cardiology.

[18]  M. Copass,et al.  Community-based interventions for sudden cardiac death. Impact, limitations, and changes. , 1992, Circulation.

[19]  E. Fain,et al.  Lidocaine causes a reversible, concentration-dependent increase in defibrillation energy requirements. , 1986, Journal of the American College of Cardiology.

[20]  T R Fleming,et al.  Designs for group sequential tests. , 1984, Controlled clinical trials.

[21]  J. A. Weigel,et al.  Initial treatment of ventricular fibrillation: defibrillation or drug therapy. , 1988, The American journal of emergency medicine.

[22]  M. Niebauer,et al.  The effect of newer antiarrhythmic drugs on defibrillation threshold , 1980, Critical care medicine.

[23]  P. Kowey,et al.  Randomized, double-blind comparison of intravenous amiodarone and bretylium in the treatment of patients with recurrent, hemodynamically destabilizing ventricular tachycardia or fibrillation. The Intravenous Amiodarone Multicenter Investigators Group. , 1995, Circulation.

[24]  L. Geddes,et al.  Elevation of ventricular defibrillation threshold in dogs by antiarrhythmic drugs. , 1979, American heart journal.

[25]  R. Kerber,et al.  Effect of lidocaine and bretylium on energy requirements for transthoracic defibrillation: experimental studies. , 1986, Journal of the American College of Cardiology.

[26]  D. Fatovich,et al.  Magnesium in cardiac arrest (the magic trial). , 1997, Resuscitation.

[27]  R. Grolleau,et al.  A randomized hemodynamic comparison of intravenous amiodarone with and without Tween 80. , 1988, European heart journal.

[28]  M. Lehmann,et al.  Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs , 1993 .

[29]  I. Stiell,et al.  Do advanced cardiac life support drugs increase resuscitation rates from in-hospital cardiac arrest? The OTAC Study Group. , 1998, Annals of emergency medicine.

[30]  D. Echt,et al.  Evaluation of antiarrhythmic drugs on defibrillation energy requirements in dogs. Sodium channel block and action potential prolongation. , 1989, Circulation.

[31]  M. Copass,et al.  Effect of epinephrine and lidocaine therapy on outcome after cardiac arrest due to ventricular fibrillation. , 1990, Circulation.

[32]  R. Gillum,et al.  Sudden coronary death in the United States: 1980-1985. , 1989, Circulation.

[33]  J. Han,et al.  Effect of procainamide on fibrillation threshold of normal and ischemic ventricles. , 1974, The American journal of cardiology.

[34]  A. Laupacis,et al.  Association of drug therapy with survival in cardiac arrest: limited role of advanced cardiac life support drugs. , 1995, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[35]  K. Nademanee,et al.  The historical development, cellular electrophysiology and pharmacology of amiodarone. , 1989, Progress in cardiovascular diseases.

[36]  L. Ekström,et al.  Lidocaine in out-of-hospital ventricular fibrillation. Does it improve survival? , 1997, Resuscitation.

[37]  M. Copass,et al.  Amplitude of ventricular fibrillation waveform and outcome after cardiac arrest. , 1985, Annals of internal medicine.

[38]  B. White,et al.  Peripheral vs central circulation times during CPR: a pilot study. , 1981, Annals of emergency medicine.

[39]  R. Califf,et al.  Randomised trial of magnesium in in-hospital cardiac arrest , 1997, The Lancet.